Animal Models and Experimental Medicine2026，Vol.9Issue(1)：P.207-214,8.DOI:10.1002/ame2.70127
The OtR tumor recurrence and metastasis model reveals doxorubicin-induced tumor shrinkage doesn''''t guarantee prolonged survival
Lingli Luo 1Ling Liu 2Minyao Deng 2Yong Jiang 2Chuan Liu 3Xiang Chen 4Xiaoxi Li2
作者信息
- 1. Department of Infection Prevention and Control,Jiangxi Chest Hospital(Jiangxi Third People’s Hospital),The Third Affiliated Hospital of Nanchang Medical College,Nanchang,China Department of Laboratory Medicine,School of Medicine,Jiangsu University,Zhenjiang,China
- 2. Department of Laboratory Medicine,School of Medicine,Jiangsu University,Zhenjiang,China
- 3. Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China
- 4. Department of Thyroid Breast Surgery,The Affiliated Yixing Hospital,of Jiangsu University,Wuxi,Jiangsu,China
- 折叠
摘要
关键词
animal models/pharmaceutical development/solid tumors分类
医药卫生引用本文复制引用
Lingli Luo,Ling Liu,Minyao Deng,Yong Jiang,Chuan Liu,Xiang Chen,Xiaoxi Li..The OtR tumor recurrence and metastasis model reveals doxorubicin-induced tumor shrinkage doesn''''t guarantee prolonged survival[J].Animal Models and Experimental Medicine,2026,9(1):P.207-214,8.
